They're still sticking to their timelines about when Renal (in particular) comes on market. Also: the market for renal has always been ~US$500m/yr. But it looks like their long term aspiration is more like $US1b so that's a good long term sign.
CB presenting at Jefferies London this Thursday (3am), page-6
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.69 |
Change
0.165(0.85%) |
Mkt cap ! $6.604B | |||
| Open | High | Low | Value | Volume |
| $19.85 | $20.00 | $19.67 | $14.04M | 707.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 408 | $19.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.69 | 2 | 1 |
View Market Depth
| Last trade - 13.56pm 20/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |